Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
6
×
boston blog main
crispr
6
×
fda
6
×
life sciences
national blog main
national top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
ipo
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
indiana blog main
indiana top stories
cancer
editas medicine
eli lilly
glaxosmithkline
medical devices
novartis
startups
abbvie
allergan
biogen
What
bio
roundup
ceo
crispr
ipo
life
medicines
moves
new
science
therapeutics
week
years
acquisitions
allogene
announced
bails
big
black
bosley's
bosley’s
brand
bridge
bridgebio
bucks
cancer
capital
car
cas
cf
collabs
companies
continue
covid
crime
crisis
cystic
daniel
deal
debut
Language
unset
unknown
Current search:
crispr
×
biotech
×
photo
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More